Literature DB >> 27584583

Stratum Corneum Tape Stripping: Monitoring of Inflammatory Mediators in Atopic Dermatitis Patients Using Topical Therapy.

Sjors A Koppes1, Richard Brans, Suzana Ljubojevic Hadzavdic, Monique H W Frings-Dresen, Thomas Rustemeyer, Sanja Kezic.   

Abstract

OBJECTIVE: The aim of this study was to explore the tape strip sampling technique in the assessment of stratum corneum levels of inflammatory mediators in a clinical trial setting.
METHODS: Thirty-eight inflammatory mediators were analyzed by a multiplex-assay in the stratum corneum, collected by adhesive tapes before and after 6 weeks of therapy, in mild and moderate atopic dermatitis (AD) patients (n = 90). Treatment was a ceramide- and magnesium-containing emollient.
RESULTS: Twenty-four mediators could quantitatively be determined. The Th2 mediators interleukin (IL)-4, IL-13, CCL2 (monocyte chemotactic protein-1), CCL22 (macrophage-derived chemokine), and CCL17 [thymus and activation-regulated chemokine (TARC)] were significantly decreased after therapy as well as IL-1β, IL-2, IL-8 (CXCL8), IL-10, acute-phase protein serum amyloid A, C-reactive protein, and vascular adhesion molecule-1. The decrease of CCL17 and IL-8 was correlated with the decrease in disease severity in a subgroup of moderate AD individuals.
CONCLUSION: Stratum corneum tape stripping offers a minimally invasive approach for studying local levels of immunomodulatory molecules in the skin. CCL17 (TARC) and IL-8 were found to be the most promising biomarkers of AD and might be useful for investigating the course of skin diseases and the effect of local therapy.
© 2016 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27584583      PMCID: PMC5296885          DOI: 10.1159/000448400

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  49 in total

1.  The colorimetric detection and quantitation of total protein.

Authors:  Randall I Krohn
Journal:  Curr Protoc Cell Biol       Date:  2002-08

2.  Validation and comparison of two multiplex technologies, Luminex and Mesoscale Discovery, for human cytokine profiling.

Authors:  Ferdousi Chowdhury; Anthony Williams; Peter Johnson
Journal:  J Immunol Methods       Date:  2008-11-05       Impact factor: 2.303

3.  Serum thymus and activation-regulated chemokine, macrophage-derived chemokine and eotaxin as markers of severity of atopic dermatitis.

Authors:  K Jahnz-Rozyk; T Targowski; E Paluchowska; W Owczarek; A Kucharczyk
Journal:  Allergy       Date:  2005-05       Impact factor: 13.146

4.  A panel of biomarkers for disease severity in atopic dermatitis.

Authors:  J L Thijs; S Nierkens; A Herath; C A F Bruijnzeel-Koomen; E F Knol; B Giovannone; M S de Bruin-Weller; D Hijnen
Journal:  Clin Exp Allergy       Date:  2015-03       Impact factor: 5.018

5.  The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4.

Authors:  T Imai; M Baba; M Nishimura; M Kakizaki; S Takagi; O Yoshie
Journal:  J Biol Chem       Date:  1997-06-06       Impact factor: 5.157

6.  CC chemokine receptor 4 expression on peripheral blood CD4+ T cells reflects disease activity of atopic dermatitis.

Authors:  M Wakugawa; K Nakamura; T Kakinuma; N Onai; K Matsushima; K Tamaki
Journal:  J Invest Dermatol       Date:  2001-08       Impact factor: 8.551

7.  TNF-α and Th2 cytokines induce atopic dermatitis-like features on epidermal differentiation proteins and stratum corneum lipids in human skin equivalents.

Authors:  Mogbekeloluwa O Danso; Vincent van Drongelen; Aat Mulder; Jeltje van Esch; Hannah Scott; Jeroen van Smeden; Abdoelwaheb El Ghalbzouri; Joke A Bouwstra
Journal:  J Invest Dermatol       Date:  2014-02-11       Impact factor: 8.551

8.  Cytokines at different stratum corneum levels in normal and sodium lauryl sulphate-irritated skin.

Authors:  Cindy M de Jongh; Maarten M Verberk; Sander W Spiekstra; Susan Gibbs; Sanja Kezic
Journal:  Skin Res Technol       Date:  2007-11       Impact factor: 2.365

9.  Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial.

Authors:  Diamant Thaçi; Eric L Simpson; Lisa A Beck; Thomas Bieber; Andrew Blauvelt; Kim Papp; Weily Soong; Margitta Worm; Jacek C Szepietowski; Howard Sofen; Makoto Kawashima; Richard Wu; Steven P Weinstein; Neil M H Graham; Gianluca Pirozzi; Ariel Teper; E Rand Sutherland; Vera Mastey; Neil Stahl; George D Yancopoulos; Marius Ardeleanu
Journal:  Lancet       Date:  2015-10-08       Impact factor: 79.321

10.  A population-based study of atopic disorders and inflammatory markers in childhood before psychotic experiences in adolescence.

Authors:  Golam M Khandaker; Stanley Zammit; Glyn Lewis; Peter B Jones
Journal:  Schizophr Res       Date:  2013-11-22       Impact factor: 4.939

View more
  15 in total

1.  Interleukin-8 Levels in the Stratum Corneum as a Biomarker for Monitoring Therapeutic Effect in Atopic Dermatitis Patients.

Authors:  Susumu Murata; Sakae Kaneko; Eishin Morita
Journal:  Int Arch Allergy Immunol       Date:  2021-01-22       Impact factor: 2.749

2.  Events in Normal Skin Promote Early-Life Atopic Dermatitis-The MPAACH Cohort.

Authors:  Jocelyn M Biagini Myers; Michael G Sherenian; Asel Baatyrbek Kyzy; Rosario Alarcon; Amen An; Zachary Flege; David Morgan; Tammy Gonzalez; Mariana L Stevens; Hua He; John W Kroner; Daniel Spagna; Brittany Grashel; Lisa J Martin; Andrew B Herr; Gurjit K Khurana Hershey
Journal:  J Allergy Clin Immunol Pract       Date:  2020-04-14

3.  Type-2 Cytokines Promote the Secretion of the Eosinophil-Attractant CCL26 by Intestinal Epithelial Cells in Food-Sensitized Patients.

Authors:  Julián Vaccaro; Karina Eva Canziani; Luciana Guzmán; Viviana Bernedo; Marcela García; Eugenia Margarita Altamirano; Emanuel Feregotti; Renata Curciarello; Cecilia Isabel Muglia; Guillermo Horacio Docena
Journal:  Front Immunol       Date:  2022-06-21       Impact factor: 8.786

4.  Tape strips from early-onset pediatric atopic dermatitis highlight disease abnormalities in nonlesional skin.

Authors:  Ana B Pavel; Yael Renert-Yuval; Jianni Wu; Ester Del Duca; Aisleen Diaz; Rachel Lefferdink; Milie M Fang; Talia Canter; Stephanie M Rangel; Ning Zhang; James G Krueger; Amy S Paller; Emma Guttman-Yassky
Journal:  Allergy       Date:  2020-08-20       Impact factor: 14.710

5.  Inhibitory Effect of Carnosol on Phthalic Anhydride-Induced Atopic Dermatitis via Inhibition of STAT3.

Authors:  Do Yeon Lee; Chul Ju Hwang; Ji Yeon Choi; Mi Hee Park; Min Ji Song; Ki Wan Oh; Dong Ju Son; Seung Hwa Lee; Sang Bae Han; Jin Tae Hong
Journal:  Biomol Ther (Seoul)       Date:  2017-09-01       Impact factor: 4.634

6.  Moderate-to-severe atopic dermatitis patients show increases in serum C-reactive protein levels, correlating with skin disease activity.

Authors:  Anjali S Vekaria; Patrick M Brunner; Ahmad I Aleisa; Lauren Bonomo; Mark G Lebwohl; Ariel Israel; Emma Guttman-Yassky
Journal:  F1000Res       Date:  2017-09-20

7.  In situ antioxidant activity of a dermo-cosmetic product: A randomized controlled clinical study.

Authors:  Virginie Ribet; Vincenzo Nobile; Ana Beatris Rossi
Journal:  Exp Dermatol       Date:  2019-09-30       Impact factor: 3.960

8.  Perillaldehyde Inhibits AHR Signaling and Activates NRF2 Antioxidant Pathway in Human Keratinocytes.

Authors:  Yoko Fuyuno; Hiroshi Uchi; Mao Yasumatsu; Saori Morino-Koga; Yuka Tanaka; Chikage Mitoma; Masutaka Furue
Journal:  Oxid Med Cell Longev       Date:  2018-02-14       Impact factor: 6.543

9.  Measurements of AMPs in stratum corneum of atopic dermatitis and healthy skin-tape stripping technique.

Authors:  Maja-Lisa Clausen; H-C Slotved; Karen A Krogfelt; Tove Agner
Journal:  Sci Rep       Date:  2018-01-26       Impact factor: 4.379

10.  Tape-Strip Proteomic Profiling of Atopic Dermatitis on Dupilumab Identifies Minimally Invasive Biomarkers.

Authors:  Helen He; Caroline M Olesen; Ana B Pavel; Maja-Lisa Clausen; Jianni Wu; Yeriel Estrada; Ning Zhang; Tove Agner; Emma Guttman-Yassky
Journal:  Front Immunol       Date:  2020-08-06       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.